Clinical Trial Update: A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of KNX100 in healthy volunteers has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• KNX100

Snippet

Sponsor: Kinoxis Therapeutics Pty Ltd | Conditions: Healthy Volunteer Study, Opioid-use Disorder | Phase 1 | Status: COMPLETED | Results posted: 2025-01-06